Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based Chemotherapy
Subjects and Methods: Seven patients with progressive localized or metastatic chemo-resistant osteosarcoma were treated by gemcitabine.The protocol included gemcitabine 1000 mg/m2/w for 7 consecutive weeks, followed by 1 week rest. If no progression was observed,ma...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2000-01-01
|
| Series: | Sarcoma |
| Online Access: | http://dx.doi.org/10.1155/S1357714X00000025 |